Drug Discovery App CS WP
-
AAV Empty/Full Ratio Assessment Using The Octet® AAVX Biosensors
9/27/2024
Learn about a rapid, high-throughput method for determining the E/F ratio in the AAV drug product that is well-suited for screening both crude and purified AAV samples.
-
Rapid, Automated, At-Line Adenovirus Quantitation
9/27/2024
Gain insight into how a high-throughput capsid assay for rapid AV quantification was developed using an innovative Bio-Layer Interferometry (BLI) platform that offers high precision and reliability.
-
Biosensors For Rapid And Direct Quantitation Of AAV Capsids
9/23/2024
Examine the performance of a biosensor for AAV capsid titer measurement that offers high-precision, broad AAV serotype binding specificity, and more.
-
Extractables In Single-Use Systems Used In ADC Manufacturing
9/23/2024
To address concerns about using organic solvents in the ADC process, extractables studies were conducted on a disposable chromatography column housing and two different disposable flow paths.
-
2024 Global Biopharma Sustainability Review
9/3/2024
What steps is the biopharma industry taking to enhance sustainability? What challenges does biopharma encounter? And how can the entire industry draw lessons from the companies setting the standard?
-
Optimized Stability Storage
8/23/2024
A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.
-
Implementing A Disaster Recovery Plan
8/23/2024
When facing a malfunction, having an effective disaster recovery plan can make the difference between a swift fix, and losing your samples and time.
-
Nitrosamine Analysis: Solutions For Risk Management And Analytical Testing
8/22/2024
Testing for nitrosamines is essential in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and drug products to ensure safety and compliance.
-
Improving Gene Therapy Development With Organ-On-A-Chip Technology
8/7/2024
Explore the current challenges of developing gene therapies, the potential of Organ-on-a-Chip technology, the future of gene therapy, and more.
-
From CLD To CDMO: Demonstrating A Successful Cell Line Technology Transfer
8/5/2024
Explore critical considerations for biopharmaceutical developers and CDMOs during technology transfer as well as a successful transfer and scale-up of a cell line from a CLD platform to a global CDMO.